1. Home
  2. GIS vs GNLX Comparison

GIS vs GNLX Comparison

Compare GIS & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Mills Inc.

GIS

General Mills Inc.

N/A

Current Price

$39.20

Market Cap

19.2B

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.74

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIS
GNLX
Founded
1866
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2B
133.0M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
GIS
GNLX
Price
$39.20
$2.74
Analyst Decision
Hold
Strong Buy
Analyst Count
16
4
Target Price
$42.07
$17.25
AVG Volume (30 Days)
8.6M
256.0K
Earning Date
03-18-2026
05-12-2026
Dividend Yield
7.08%
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
$2,037,800,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.11
N/A
52 Week Low
$31.75
$2.29
52 Week High
$51.33
$8.54

Technical Indicators

Market Signals
Indicator
GIS
GNLX
Relative Strength Index (RSI) 65.73 46.01
Support Level $35.45 $2.39
Resistance Level $39.56 $3.05
Average True Range (ATR) 1.00 0.20
MACD 0.23 -0.02
Stochastic Oscillator 97.73 37.93

Price Performance

Historical Comparison
GIS
GNLX

About GIS General Mills Inc.

General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: